GB2333527A - Therapeutic gene - Google Patents

Therapeutic gene

Info

Publication number
GB2333527A
GB2333527A GB9904141A GB9904141A GB2333527A GB 2333527 A GB2333527 A GB 2333527A GB 9904141 A GB9904141 A GB 9904141A GB 9904141 A GB9904141 A GB 9904141A GB 2333527 A GB2333527 A GB 2333527A
Authority
GB
Grant status
Application
Patent type
Prior art keywords
dd
fusion protein
th
polynucleotide sequences
therapeutic genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9904141A
Other versions
GB2333527B (en )
GB9904141D0 (en )
Inventor
Alan John Kingsman
Susan Mary Kingsman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica (UK) Ltd
Original Assignee
Oxford Biomedica (UK) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Abstract

Polynucleotide sequences and vectors containing them, for use in gene therapy, the polynucleotide sequences comprising two or more therapeutic genes operably linked to a promoter and encoding a fusion protein product of the therapeutic genes. The fusion protein may be for example a tyrosine hydroxylase (TH)-DOPA decarboxylase (DD) fusion protein in either TH-DD or DD-TH order, useful for treating Parkinson's disease.
GB9904141A 1996-10-29 1997-10-28 Therapeutic gene Expired - Lifetime GB2333527B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9622500A GB9622500D0 (en) 1996-10-29 1996-10-29 Therapeutic gene
PCT/GB1997/002969 WO1998018934A1 (en) 1996-10-29 1997-10-28 Therapeutic gene
GB9904141A GB2333527B (en) 1996-10-29 1997-10-28 Therapeutic gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9904141A GB2333527B (en) 1996-10-29 1997-10-28 Therapeutic gene

Publications (3)

Publication Number Publication Date
GB9904141D0 GB9904141D0 (en) 1999-04-14
GB2333527A true true GB2333527A (en) 1999-07-28
GB2333527B GB2333527B (en) 2001-05-02

Family

ID=26310304

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9904141A Expired - Lifetime GB2333527B (en) 1996-10-29 1997-10-28 Therapeutic gene

Country Status (1)

Country Link
GB (1) GB2333527B (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012109A1 (en) * 1988-06-03 1989-12-14 The United States Of America, As Represented By Th Gene therapy using gene fusions for genetic or acquired disorders
WO1992007945A1 (en) * 1990-10-30 1992-05-14 Dana Farber Cancer Institute Cell type specific alteration of levels of gene products in neural cells
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
US5344923A (en) * 1992-09-29 1994-09-06 The Ohio State University Research Foundation Nucleotide sequence encoding for bifunctional enzyme for proline production
US5359035A (en) * 1985-12-21 1994-10-25 Hoechst Aktiengesellschaft Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
WO1995028493A1 (en) * 1994-04-13 1995-10-26 The Rockefeller University Aav-mediated delivery of dna to cells of the nervous system
WO1995034670A2 (en) * 1994-06-06 1995-12-21 Children's Hospital, Inc. Recombinant aav genome encoding immunodeficiency virus protein
WO1996005319A1 (en) * 1994-08-12 1996-02-22 Arch Development Corporation Genetically engineered cells that produce dopamine
WO1996037621A2 (en) * 1995-05-23 1996-11-28 Morphosys Gesellschaft Für Proteinoptimierung Mbh Multimeric proteins
WO1997018319A1 (en) * 1995-11-14 1997-05-22 Somatix Therapy Corporation Joint expression of gtp cyclohydrolase and tyrosine hydroxylase

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359035A (en) * 1985-12-21 1994-10-25 Hoechst Aktiengesellschaft Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
WO1989012109A1 (en) * 1988-06-03 1989-12-14 The United States Of America, As Represented By Th Gene therapy using gene fusions for genetic or acquired disorders
WO1992007945A1 (en) * 1990-10-30 1992-05-14 Dana Farber Cancer Institute Cell type specific alteration of levels of gene products in neural cells
US5344923A (en) * 1992-09-29 1994-09-06 The Ohio State University Research Foundation Nucleotide sequence encoding for bifunctional enzyme for proline production
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
WO1995028493A1 (en) * 1994-04-13 1995-10-26 The Rockefeller University Aav-mediated delivery of dna to cells of the nervous system
WO1995034670A2 (en) * 1994-06-06 1995-12-21 Children's Hospital, Inc. Recombinant aav genome encoding immunodeficiency virus protein
WO1996005319A1 (en) * 1994-08-12 1996-02-22 Arch Development Corporation Genetically engineered cells that produce dopamine
WO1996037621A2 (en) * 1995-05-23 1996-11-28 Morphosys Gesellschaft Für Proteinoptimierung Mbh Multimeric proteins
WO1997018319A1 (en) * 1995-11-14 1997-05-22 Somatix Therapy Corporation Joint expression of gtp cyclohydrolase and tyrosine hydroxylase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PROC.NATL.ACAD.SCI. 1993 90 pgs 7889-7893 MARASCO et al. *

Also Published As

Publication number Publication date Type
GB2333527B (en) 2001-05-02 grant
GB9904141D0 (en) 1999-04-14 grant

Similar Documents

Publication Publication Date Title
WO1999014346A3 (en) SENSE mRNA THERAPY
EP1038958A4 (en) HUMAN Nap1 PROTEIN
WO1995027070A1 (en) Dna expression vectors for use in the treatment of vascular diseases by gene therapy
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
JPS63304985A (en) Novel plasmid
CA2162577A1 (en) Human immunoglobulin vh gene segments and dna fragments containing the same
JPS6460699A (en) Tanning aid, its use and leather tanning method
JPS6058076A (en) Dna base arrangement and preparation of recombinant plasmid containing it
JPS62126978A (en) Novel dna sequence coding human tissue plasminogen activation factor derived from human normal cell and vector and cell containing said dna sequence
CA2120153A1 (en) Recombinant immunotoxins
DK20387A (en) Process for the continuous heat treatment of foodstuffs for human consumption, as well as apparatus in implementation of the procedure
WO1999047152A3 (en) Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells
Sala et al. Problems of Excessive Energy Consumption of Heat Treatment in Metallurgy
WO2002010400A1 (en) A NOVEL POLYPEPTIDE- tRNA GUANINE GLYCOSYLETRANSFERASE 17.82 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20171027